COVID-19

Interleukin-6 Receptor antagonists in critically ill patients with COVID-19

Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine

BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting

Efficacy of the ChAdOx1 nCoV-19 COVID-19 vaccine against the B.1.351 variant

For April 2021, we have selected: Pun B.T. et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021; 9:239-250. doi: 10.1016/S2213-2600(20)30552-X.

The fifth episode of the podcast series “One Voice for Neurology” focuses on research in neuroscience. Three guests have been interviewed: Prof. Monica di Luca, president of the European Brain Council, Jane Ransom, executive director of the American Brain Foundation and Dr. Paulo Fontoura, Global Head of Clinical Development Neuroscience at Roche.

COVID-19 around the World: Clinician interviews on experience and impact of the virus (Cape Verde)

Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms

COVID-19 continuous-EEG case series: A Descriptive Study

Acute ischemic stroke and COVID-19: An analysis of 27 676 Patients

Inflammatory cytokine patterns associated with neurological diseases in COVID-19

Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection

Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6

Neurological manifestations as primary presentation of COVID-19 in hospitalized patients

Cerebrospinal fluid in COVID-19: A systematic review of the literature